Our ongoing research studies aim to improve the accuracy of genetic diagnosis and risk prediction by characterising disease-associated NF2 variants and assessing genotype-phenotype correlations. We also aim to characterise the mechanism of action of variants that cause NF2-related schwannomatosis in more detail to understand schwannoma disease pathogenesis more clearly.